Bolt Biotherapeutics, Inc.

NasdaqGS:BOLT Stock Report

Market Cap: US$42.3m

Bolt Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BOLT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Dec 23BuyUS$7,125William QuinnIndividual7,500US$0.95
06 Dec 23BuyUS$4,116William QuinnIndividual4,329US$1.18
06 Dec 23BuyUS$4,401Edith PerezIndividual4,570US$1.18
06 Dec 23BuyUS$1,955Grant YonehiroIndividual2,500US$0.78
06 Dec 23BuyUS$4,909Randall SchatzmanIndividual5,000US$1.18
30 Nov 23SellUS$128,993Vivo Capital, LLCCompany148,884US$0.91
21 Nov 23SellUS$3,060Vivo Capital, LLCCompany3,400US$0.90
20 Nov 23SellUS$79,933Vivo Capital, LLCCompany86,054US$0.96

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BOLT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,2360.0216%
Individual Insiders1,515,4423.97%
Hedge Funds6,111,20216%
Institutions9,097,80923.9%
VC/PE Firms9,334,14724.5%
General Public12,060,90431.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 67.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.58%
Tang Capital Management, LLC
3,652,244US$4.1m2.68%0.47%
9.24%
Vivo Capital, LLC
3,521,291US$3.9m-9.04%0.32%
8.02%
Pivotal BioVenture Partners LLC
3,058,419US$3.4m0%1.39%
7.22%
Sofinnova Investment, Inc.
2,754,437US$3.1m0%0.24%
6.45%
Citadel Advisors LLC
2,458,958US$2.7m-13.8%no data
4.07%
Newtyn Management, LLC
1,553,535US$1.7m52.3%0.22%
4.04%
OrbiMed Advisors LLC
1,541,000US$1.7m0%0.03%
3.2%
Edgar Engleman
1,220,281US$1.4m0%no data
2.75%
Samsara BioCapital LLC
1,049,153US$1.2m0%0.24%
2.44%
The Vanguard Group, Inc.
931,129US$1.0m0.74%no data
1.89%
Stanford Management Company
719,546US$798.7k-4.96%0.05%
1.31%
Adage Capital Management, L.P.
500,000US$555.0k0%no data
1.21%
Acuitas Investments, LLC
459,455US$510.0k-0.2%0.19%
1.17%
Renaissance Technologies LLC
445,273US$494.3k41.7%no data
1.09%
Hawkeye Capital Management, LLC
415,039US$460.7k0%1.18%
0.92%
Geode Capital Management, LLC
350,164US$388.7k-2.93%no data
0.67%
BlackRock, Inc.
257,271US$285.6k-0.29%no data
0.46%
Kam Chung Leung
173,698US$192.8k0%no data
0.31%
Privium Fund Management (UK) Limited
116,516US$129.3k0%0.09%
0.29%
Bridgeway Capital Management, LLC
111,200US$123.4k0%no data
0.25%
Marquette Asset Management, LLC
96,673US$107.3k-1.19%0.02%
0.21%
Squarepoint OPS LLC
79,772US$88.5k-0.33%no data
0.21%
Morgan Stanley, Investment Banking and Brokerage Investments
79,394US$88.1k-50.3%no data
0.21%
FMR LLC
79,191US$87.9k0%no data
0.17%
Two Sigma Securities, LLC, Asset Management Arm
64,232US$71.3k0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.